Theresa Greco's most recent trade in OptimizeRx Corp was a trade of 1,420 Common Stock done at an average price of $12.7 . Disclosure was reported to the exchange on Dec. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.74 per share. | 23 Dec 2025 | 1,420 | 72,868 (0%) | 0% | 12.7 | 18,091 | Common Stock |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.49 per share. | 01 Nov 2025 | 1,693 | 74,288 (0%) | 0% | 20.5 | 34,690 | Common Stock |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2025 | 35,156 | 35,156 | - | - | Stock Option | |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2025 | 15,625 | 75,981 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 12,133 | 12,133 | - | - | Stock Option | |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 7,042 | 60,356 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 2,441 | 53,314 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 29,153 | 29,153 | - | - | Stock Option | |
| OptimizeRx Corp | Greco Theresa | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 15,528 | 50,873 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.15 per share. | 01 Nov 2024 | 1,693 | 35,345 (0%) | 0% | 5.2 | 8,719 | Common Stock |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2023 | 35,758 | 35,758 | - | - | Stock Option | |
| OptimizeRx Corp | Theresa Greco | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2023 | 18,519 | 37,038 (0%) | 0% | 0 | Common Stock |